Free Trial

Evoke Pharma (EVOK) SEC Filings & 10K Form

Evoke Pharma logo
$2.25 -0.07 (-3.02%)
Closing price 03:51 PM Eastern
Extended Trading
$2.24 -0.01 (-0.44%)
As of 04:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Evoke Pharma SEC Filings

DateFilerForm TypeView
03/24/2025
5:47 PM
Bleichroeder LP (Filed by)
Evoke Pharma (Subject)
Form SCHEDULE 13G/A
03/24/2025
3:30 PM
Evoke Pharma (Issuer)
Kowieski Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
3:30 PM
D'Onofrio Matthew J (Reporting)
Evoke Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
6:15 PM
Bleichroeder LP (Filed by)
Evoke Pharma (Subject)
Form SCHEDULE 13G/A
02/24/2025
7:30 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2025
3:47 PM
Evoke Pharma (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SCHEDULE 13D/A
01/30/2025
5:39 PM
Evoke Pharma (Issuer)
Harkey Wilmot B. (Reporting)
Mack Daniel (Reporting)
Nantahala Capital Management, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
3:30 PM
CARLSON MARILYN R. (Reporting)
Evoke Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
3:30 PM
Evoke Pharma (Issuer)
Kowieski Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
3:30 PM
Evoke Pharma (Issuer)
GARNER CAM L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
3:30 PM
Brady Todd C (Reporting)
Evoke Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
3:30 PM
Evoke Pharma (Issuer)
REED VICKIE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
3:30 PM
Evoke Pharma (Issuer)
Hill Malcolm R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
3:30 PM
Evoke Pharma (Issuer)
WIDDER KENNETH J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
3:30 PM
D'Onofrio Matthew J (Reporting)
Evoke Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
3:31 PM
Evoke Pharma (Issuer)
Harkey Wilmot B. (Reporting)
Mack Daniel (Reporting)
Nantahala Capital Management, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/14/2024
8:19 AM
Altium Capital Management LP (Filed by)
Evoke Pharma (Subject)
Form SC 13G/A
10/29/2024
6:47 PM
Evoke Pharma (Subject)
HIRSCHMAN ORIN (Filed by)
Form SC 13G/A
10/28/2024
7:10 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
4:07 PM
Evoke Pharma (Issuer)
Smeal Benjamin C. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/22/2024
4:09 PM
Evoke Pharma (Issuer)
Smeal Benjamin C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
8:00 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
3:15 PM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
4:08 PM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
4:11 PM
Evoke Pharma (Filer)
Form 424B3
09/20/2024
6:28 PM
Evoke Pharma (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SC 13D
09/08/2024
11:15 PM
Evoke Pharma (Filer)
Form EFFECT
08/29/2024
3:16 PM
Evoke Pharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/21/2024
11:15 PM
Evoke Pharma (Filer)
Form EFFECT
08/16/2024
6:00 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
7:15 AM
Evoke Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2024
7:20 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
4:11 PM
Evoke Pharma (Issuer)
Kowieski Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
3:48 PM
D'Onofrio Matthew J (Reporting)
Evoke Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
6:00 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
6:01 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
7:00 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2024
5:09 PM
Evoke Pharma (Issuer)
Kowieski Mark (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/28/2024
3:17 PM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2024
3:53 PM
Brady Todd C (Reporting)
Evoke Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:58 PM
Evoke Pharma (Filer)
Form ARS/A
Trump’s betrayal exposed (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
05/14/2024
3:20 PM
Evoke Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
3:05 PM
Evoke Pharma (Filer)
Form 10-K/A
05/14/2024
3:00 PM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
2:34 PM
Evoke Pharma (Filer)
Form DEF 14A
04/10/2024
2:35 PM
Evoke Pharma (Filer)
Form DEFA14A
04/10/2024
2:36 PM
Evoke Pharma (Filer)
Form ARS
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:EVOK) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners